Tenax Therapeutics (NASDAQ:TENX) Now Covered by Analysts at StockNews.com
Analysts at StockNews.com started coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Several other equities research analysts also recently issued reports on TENX. Leerink Partners set a $20.00 price objective on […]
Analysts at StockNews.com started coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Several other equities research analysts also recently issued reports on TENX. Leerink Partners set a $20.00 price objective on […]
